This monograph contains both the OEL and ADE. Colchicine is an anti-gout preparation. Colchicine is used for acute gout attacks to reduce pain and inflammation. It may be used on long-term basis to prevent or reduce the frequency of attacks. Colchicine is used on long-term basis to prevent fever and recurrent inflammation of membranes. Colchicine is effective in preventing the inflammation of tissues around the heart. olchicine has been showed to be effective in the treatment of blood vessel, skin and mucosal inflammation symptoms. Colchicine has been used in the treatment of autoimmune-based thickening of the skin and lymph node enlargement due to inflammatory cell accumulation. Colchicine is highly potent and will require validated engineering controls in order to control occupational exposures down to an acceptable airborne concentration. To order this occupational exposure limit monograph for immediate download, click on the order now button to the right.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Colchicine, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.